ESMO 2022 Conference Coverage


 

ESMO 2022 on the Inflammatory Biomarkers as a Prognostic Scoring Model for Malignant Peritoneal Mesothelioma

17 views
October 10, 2022
Comments 0
Login to view comments. Click here to Login